Wells Fargo & Company Sangamo Therapeutics, Inc Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 60,066 shares of SGMO stock, worth $112,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,066
Previous 64,973 7.55%
Holding current value
$112,924
Previous $23,000 121.74%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$0.32 - $1.1 $1,570 - $5,397
-4,907 Reduced 7.55%
60,066 $51,000
Q2 2024

Aug 13, 2024
SELL
$0.36 - $0.65 $24,978 - $45,099
-69,384 Reduced 51.64%
64,973 $23,000
Q1 2024

May 10, 2024
SELL
$0.42 - $1.38 $15,350 - $50,436
-36,548 Reduced 21.38%
134,357 $90,000
Q4 2023

Feb 09, 2024
SELL
$0.3 - $0.63 $46,129 - $96,872
-153,766 Reduced 47.36%
170,905 $92,000
Q3 2023

Nov 13, 2023
SELL
$0.58 - $1.47 $12,993 - $32,930
-22,402 Reduced 6.45%
324,671 $194,000
Q2 2023

Aug 15, 2023
SELL
$1.11 - $1.74 $185,708 - $291,110
-167,305 Reduced 32.53%
347,073 $451,000
Q1 2023

May 12, 2023
BUY
$1.66 - $3.67 $189,082 - $418,031
113,905 Added 28.44%
514,378 $905,000
Q4 2022

Feb 13, 2023
SELL
$2.77 - $5.07 $126,107 - $230,816
-45,526 Reduced 10.21%
400,473 $1.26 Million
Q3 2022

Nov 14, 2022
SELL
$4.27 - $6.39 $125,888 - $188,389
-29,482 Reduced 6.2%
445,999 $2.19 Million
Q2 2022

Aug 12, 2022
SELL
$3.28 - $6.21 $356,211 - $674,412
-108,601 Reduced 18.59%
475,481 $1.97 Million
Q1 2022

May 16, 2022
SELL
$5.23 - $7.82 $107,853 - $161,264
-20,622 Reduced 3.41%
584,082 $3.39 Million
Q4 2021

Feb 14, 2022
SELL
$7.29 - $10.97 $379,881 - $571,646
-52,110 Reduced 7.93%
604,704 $4.54 Million
Q3 2021

Nov 15, 2021
SELL
$9.01 - $12.01 $300,780 - $400,929
-33,383 Reduced 4.84%
656,814 $5.92 Million
Q2 2021

Aug 16, 2021
BUY
$10.17 - $12.64 $317,731 - $394,898
31,242 Added 4.74%
690,197 $8.26 Million
Q1 2021

May 13, 2021
SELL
$10.88 - $17.05 $1.44 Million - $2.25 Million
-132,125 Reduced 16.7%
658,955 $8.26 Million
Q4 2020

Feb 09, 2021
SELL
$9.23 - $18.18 $534,786 - $1.05 Million
-57,940 Reduced 6.82%
791,080 $12.3 Million
Q3 2020

Nov 05, 2020
BUY
$9.38 - $12.48 $324,820 - $432,169
34,629 Added 4.25%
849,020 $8.02 Million
Q2 2020

Aug 13, 2020
BUY
$6.21 - $11.83 $902,027 - $1.72 Million
145,254 Added 21.71%
814,391 $7.3 Million
Q1 2020

May 14, 2020
BUY
$5.05 - $8.85 $3.38 Million - $5.92 Million
669,137 New
669,137 $4.26 Million

Others Institutions Holding SGMO

# of Institutions
115
Shares Held
56.4M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $294M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email